United States
US 12,702,739 B1
Device and method for administering an anti cancer substance
US 12,702,739 B1 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Individual. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Individual
- Inventors
- Brian J. Leberthon
- Publication date
- 2026-08-11
- Filing date
- 2021-05-13
- Document type
- B1 Granted patent
- Also written as
- US 12,702,739 B1 · US12702739 · 12702739
Abstract
An anti-cancer substance is administered via the patient's blood ex vivo and in line by establishing a connection between the patient and a device having a chamber containing the anti-cancer substance. The patient's blood in the chamber and the anti-cancer substance interact so that immune cells in the blood (1) are activated to produce an immune response in the patient, or (2) are pre-armed by attaching to the cells antibodies, or (3) both. After activating or pre-arming the cells, the patient's treated blood is returned to the patient.…
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free